Odyssey Therapeutics, Inc. (ODTX)
19.00
+0.88
(+4.86%)
USD |
NASDAQ |
Oct 09, 16:00
18.92
-0.08
(-0.42%)
After-Hours: 20:00
Odyssey Therapeutics EPS Diluted (Quarterly) : -1.102 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.102 |
| March 31, 2026 | -0.7966 |
| June 30, 2025 | -0.8585 |
| Date | Value |
|---|---|
| March 31, 2025 | -0.8002 |
| December 31, 2024 | -0.7808 |
| December 31, 2023 | -0.7173 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.1822 |
| Alnylam Pharmaceuticals, Inc. | 1.207 |
| Anika Therapeutics, Inc. | 0.2412 |
| Savara, Inc. | -0.1587 |
| Vericel Corp. | 0.0422 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -52.79M |
| Total Expenses (Quarterly) | 52.79M |
| Enterprise Value | 624.18M |
| Earnings Yield | -18.72% |
| Normalized Earnings Yield | -18.52 |